Recently, Jiang et al. reported differences in SHP2 expression between tumor (T) and adjacent non-tumor (NT) tissues and divided HCCs into two groups depending on the level of SHP2 expression: T < NT and T ≥ NT. The gene discussed is PTPN11; the disease is neoplasm.